Combination therapy with rituximab may benefit elderly patients with DLBCLHealioIn elderly patients with diffuse large B-cell lymphoma, a combination therapy regimen that includes rituximab appears to yield successful response rates, according to recen…
|
Experimental drug could fight slow-growing cancers
OCRegister In one trial, 220 patients with recurrent chronic lymphocytic leukemia were given an intravenous drug called rituximab, a standard treatment. Half of participants were also given idelalisib twice a day in pill form. • Overall, 81 percent of patients … |
|
Pipeline Progress at Prothena
Zacks.com Moreover, Roche and Prothena will initiate a research collaboration focusing on optimizing early stage antibodies targeting alpha-synuclein. This research collaboration will include incorporation of Roche’s proprietary Brain Shuttle(TM) technology to … Why Prothena Corporation PLC Shares Leaped HigherMotley Fool First Human Dosed in Phase 1 Study of PRX002 for Treatment of Parkinson’s …GlobeNewswire (press release) |
The Express TribuneSea otters can get the flu, tooEureka! Science NewsThe researchers discovered antibodies for the 2009 H1N1 flu virus in blood samples from 70 percent of the sea otters studied. None of the otters were visibly sick, but the presence o…
Single-dose PCV2 Vaccine in Sows Induces Transfer of AntibodiesThePigSite.comSPAIN – A recent CReSA study has investigated the presence of porcine circovirus type 2 (PCV2) DNA and antibodies to the virus in serum and colostrum of sows vaccinated before…
Single-dose PCV2 Vaccine in Sows Induces Transfer of Colostral AntibodiesThePigSite.comSPAIN – A recent CReSA study has investigated the presence of porcine circovirus type 2 (PCV2) DNA and antibodies to the virus in serum and colostrum of sows vaccina…
Single Dose Vaccine Against PCV2 in Sows Induces Transfer of Colostral …ThePigSite.comSPAIN – A recent CReSA study has investigated the presence of porcine circovirus type 2 (PCV2) DNA and antibodies to the virus in serum and colostrum of sows vaccin…
World Biosimilar Sector Developments Traced by FirstWord in New Report …Virtual-Strategy Magazine (press release)The leading amid the biosimilar and NCB development league is Rituximab (Rituxan/MabThera; Roche), possessing more than 30 individual pro…
World Biosimilar Sector Developments Traced by FirstWord in New Report …DigitalJournal.comThe leading amid the biosimilar and NCB development league is Rituximab (Rituxan/MabThera; Roche), possessing more than 30 individual programmes worldwide. The …
World Biosimilar Sector Developments Traced by FirstWord in New Report …PR Web (press release)The leading amid the biosimilar and NCB development league is Rituximab (Rituxan/MabThera; Roche), possessing more than 30 individual programmes worldwide. …